CL2011000717A1 - Compound derived from purine nucleoside phosphoramidate, a hydrate or solvate thereof; composition that includes it; preparation process, useful for the treatment of hepatitis C virus (vhc) infection. - Google Patents
Compound derived from purine nucleoside phosphoramidate, a hydrate or solvate thereof; composition that includes it; preparation process, useful for the treatment of hepatitis C virus (vhc) infection.Info
- Publication number
- CL2011000717A1 CL2011000717A1 CL2011000717A CL2011000717A CL2011000717A1 CL 2011000717 A1 CL2011000717 A1 CL 2011000717A1 CL 2011000717 A CL2011000717 A CL 2011000717A CL 2011000717 A CL2011000717 A CL 2011000717A CL 2011000717 A1 CL2011000717 A1 CL 2011000717A1
- Authority
- CL
- Chile
- Prior art keywords
- hepatitis
- virus
- treatment
- vhc
- solvate
- Prior art date
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compuesto cristalino derivado de fosforamidato de nucleósido de purina; composición farmacéutica; método de tratamiento del virus de la hepatitis C (HVC); proceso para prepararlo; y método para determinar cristalinidad del compuesto.Crystalline compound derived from purine nucleoside phosphoramidate; pharmaceutical composition; method of treatment of hepatitis C virus (HVC); process to prepare it; and method to determine crystallinity of the compound.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31954810P | 2010-03-31 | 2010-03-31 | |
US33594010P | 2010-06-17 | 2010-06-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2011000717A1 true CL2011000717A1 (en) | 2012-04-09 |
Family
ID=47146037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2011000717A CL2011000717A1 (en) | 2010-03-31 | 2011-03-31 | Compound derived from purine nucleoside phosphoramidate, a hydrate or solvate thereof; composition that includes it; preparation process, useful for the treatment of hepatitis C virus (vhc) infection. |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR081813A1 (en) |
CL (1) | CL2011000717A1 (en) |
-
2011
- 2011-03-31 CL CL2011000717A patent/CL2011000717A1/en unknown
- 2011-03-31 AR ARP110101097 patent/AR081813A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR081813A1 (en) | 2012-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015502799A1 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
PH12020551055A1 (en) | Methods for treating filoviridae virus infections | |
EA201590943A1 (en) | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND THEIR ANALOGUES | |
PH12018500931A1 (en) | Hcv polymerase inhibitors | |
PH12015502273A1 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
UA116083C2 (en) | Purine derivatives for the treatment of viral infections | |
PH12016502563A1 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
PH12014502094A1 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
PH12016500660A1 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
BR112017013028A2 (en) | nucleosides, nucleotides and analogs thereof substituted | |
UY33620A (en) | NUCLEOSID AND NUCLEOTIDE AZIDO ANALOGS | |
PH12017501598A1 (en) | �-D-2`-DEOXY-2`a-FLUORO-2`-�-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT | |
PH12015501017A1 (en) | Alternative uses for hbv assembly effectors | |
CL2011000717A1 (en) | Compound derived from purine nucleoside phosphoramidate, a hydrate or solvate thereof; composition that includes it; preparation process, useful for the treatment of hepatitis C virus (vhc) infection. |